Israeli Tycoons’ Holding Groups Have Been Cut Down to Size
Research finds their share of the Tel Aviv Stock Exchange and economy has dropped sharply in the last six years
Tel Aviv Stock Exchange
Teva Shares Crash as Settlement Plan for Opioid Suits in the U.S. Is Proposed
Israeli drug giant's shares dropped more than 13% on the Tel Aviv Stock Exchange the same day the company's chief financial officer announced his resignation
BlackRock Funds Raise Israeli Ire
U.S. giant launches 15 ETFs on the Tel Aviv Stock Exchange that investors can buy in shekels
Tel Aviv Stock Exchange Defies Doubters to Win a $200m Valuation in Its IPO
The final results aren’t in yet, but foreign investors are believed to have bought most of the stock
Locals Doubtful About Tel Aviv Bourse’s IPO
Foreign investors, however, said to look favorably at TASE’s potential as a for-profit corporation
Tel Aviv Stock Exchange Launches Initial Public Offering
TASE plans to sell 31.7 million shares at 7 shekels per share
Toronto Bourse Luring More Israel Firms, and Not Just in Marijuana
The TSX has made itself tech-friendly and counts seven Israeli IPOs since 2013
Israel's Delta Buys a Maker of Victoria’s Secret Bras
Israeli company will pay nothing upfront for Hong- Kong-based Bogart but will cover debt and may make payment later
Tel Aviv Exchange Files for IPO, to Be Led by U.S. Firm Jefferies
Bourse sees offering as step toward upgrading Israel’s flagging capital market
Israel’s Medical Marijuana Stock Bubble Is Starting to Deflate
Industry faces delay in amended export regulations ■ FDA sounds skeptical note on CBDs
Surprise Strike Shuts Tel Aviv Stock Exchange for Five Hours
Foreign traders shocked and paralyzed as TASE trading fails to open at usual time because of strife between union, management ■ Trading set to open 1:15 P.M. Israel time ■ Union spokesman denies strike, blames CEO for cutting staff
Billionaire Buffett Has Probably Taken $213 Million Loss on His Teva Stock
Legendary investor had 3.9% stake in drug marker at end of first quarter
Analysis Teva’s Legal Woes Threaten Its Ability to Repay Heavy Debt
The drug maker not only faces price-fixing allegations in the U.S. but also is a party to a suit on opiod abuse
Gad Zeevi Returns After 20 Years With New Bid for Bezeq
The offer sends shares of the beleaguered telecoms group soaring
Ailing Cellcom Putting Elsztain’s Empire in Jeopardy
The cellular company may need a capital infusion and that could upset the IDB group’s delicate debt position
Bank Hapoalim to Sell Credit Card Unit in a Giant IPO
Bank sets aside another $246 million to cover costs of U.S. tax probe
Tel Aviv Shares Open Higher Despite Netanyahu Draft Indictment
Israeli stock market had been closed since attorney general announced he intends to indict the prime minister
Business in Brief: Trump China Tariff Delay Lifts Tel Aviv Shares
TASE getting another medical marijuana firm ■ Secondary bourse could begin in 2020 ■ Warburg brings in three partners as it completes acquisition of Leumi Card ■ Securities Authority to focus on making Israeli market more attractive to investors
Africa Israel Deal Close as Bondholders Accept Offer
Mega Or and Big Shopping Centers make last-minute bid to buy company’s chief asset, pushing out Moti Ben-Moshe
Business in Brief: TASE Expects IPO to Go Ahead This Year
Securities investigators raid five companies on fraud, insider-trading suspicions ■ Day ends with mild losses
Business in Brief: Tel Aviv Stock Exchange Hires Comedian to Tout Investing in Shares
After year’s wait, KLA-Tencor’s acquisition of Orbotech to be completed Wednesday ■ U.S. hedge fund Starboard sells Mellanox stock at big profit ■ Tel Aviv shares eke out gain in thin trading
Pot Luck: Investing in Israeli Medical Cannabis Stocks Is Guesswork
The growing number of shares trading on the Tel Aviv Stock Exchange have soared based mostly on investors’ inchoate hopes – not on fundamentals
Business in Brief: TASE CEO Says Government Is Undercutting Capital Markets
Tel Aviv shares mark their fifth rise in last six sessions ■ Buffet’s Berkshire Hathaway sees Teva holding lose $264 million in value ■ Ratio Petroleum soars on start of Guyana oil exploration ■ Plus500 admits to typo that misled investors about losses
Business in Brief: Bezeq to Petition Court on Merging Units
Plantext to be first Israeli cannabis company to be traded overseas ■ Stanley Fischer hired to advise BlackRock ■ Wall Street weighs down Tel Aviv shares
Business in Brief: Super Pharm Gearing Up for Tel Aviv Stock Exchange IPO
Tel Aviv shares end higher, despite Teva Pharmaceuticals selloff ■ Bondholders backing alternative to Africa Properties
Teva Shares Take Tumble After Warning of Bleak 2019
Israeli drug maker sees a repeat this year of the tough market conditions of 2018
Business in Brief: Tel Aviv Shares Mixed in Quiet Trading Day
Latest Africa Israel bailout proposal fails ■ Internet Gold edges to liquidation after failing to get improved offer for B Com
Business in Brief: Dan Bus Company to Sell 35% Stake in Private Placement
Paz Oil building power plant ■ Stocks fall as Israel Chemicals tumbles
Business in Brief: Bank Hapoalim Plans Largest IPO of the Year
Coca-Cola Israel bids on South African food firm Clover ■ TASE stays basically unchanged
Business in Brief: Tel Aviv Shares Eke Out Gains as Energy Shares Rally
Teva migraine drug fails to win coverage by major pharma benefit manager ■ S&P affirms Israel’s credit rating despite fiscal setbacks